Location History:
- Palo Alto, CA (US) (2022)
- Stanford, CA (US) (2022)
Company Filing History:
Years Active: 2022
Title: Innovations of Tzuhua Dennis Lin in Stem Cell Research
Introduction
Tzuhua Dennis Lin is a prominent inventor based in Palo Alto, CA, known for his significant contributions to the field of stem cell research. He holds two patents that focus on innovative methods for treating inflammation-associated ailments using mesenchymal stem cells.
Latest Patents
His latest patents include "Mesenchymal stem cells expressing anti-inflammatory cytokines and methods of use" and "Systemic targeting of inflammatory sites and enhanced immunomodulatory function by introducing the chimeric antigen receptor (CAR) into mesenchymal stem cells for inflammatory and autoimmune diseases." The first patent provides compositions and methods for producing anti-inflammatory cytokines, growth factors, or chemokines. It details nucleic acids that include an NFκB inflammation response element operably linked to a nucleotide sequence encoding an anti-inflammatory cytokine, such as IL-4. The second patent describes engineered mesenchymal stromal cells that express a chimeric antigen receptor, specifically targeting activated myeloid cells for the treatment of inflammation.
Career Highlights
Tzuhua Dennis Lin is affiliated with Leland Stanford Junior University, where he conducts research and develops innovative solutions in the realm of stem cell therapy. His work has the potential to revolutionize treatments for various inflammatory and autoimmune diseases.
Collaborations
He collaborates with esteemed colleagues, including Stuart Barry Goodman and Sai-Wen Tang, to advance the field of stem cell research and its applications in medicine.
Conclusion
Tzuhua Dennis Lin's innovative work in stem cell research and his patents highlight his commitment to developing effective treatments for inflammation-related conditions. His contributions are paving the way for future advancements in medical therapies.